Moreau, P.; Rabin, N.; Plesner, T.; Weisel, K.; Sonneveld, P.; Mateos, M-V.; Schecter, J.M.; Amin, H.; Trivedi, S.; Dimopoulos, M.A. . (2017). 998PDManagement of infusion-related reactions (IRRs) in patients (pts) receiving daratumumab plus standard of care for the treatment of multiple myeloma (MM) in the phase 3 studies CASTOR and POLLUX. Annals of Oncology, 28(suppl_5), –.
doi:10.1093/annonc/mdx373.004
